| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/06/2004 | US6716598 Isolating adjusted polypeptide; obtain sample, incubate with binding agent, filter mixture, remove leaching agent, isolate polypeptide |
| 04/06/2004 | US6716594 Monoclonal antibody |
| 04/06/2004 | US6716592 Materials and methods relating to the diagnosis and treatment of diabetes and obesity |
| 04/06/2004 | US6716587 Antiinflammatory |
| 04/06/2004 | US6716586 Insulin-like growth factor agonist molecules |
| 04/06/2004 | US6716575 Diagnosis and treatment of AUR1 and/or AUR2 related disorders |
| 04/06/2004 | US6716410 Using humanized monoclonal antibody (mab) or fragment with variable chain with oxidation specific epitopes |
| 04/06/2004 | CA2147372C Multidrug resistance gene |
| 04/06/2004 | CA2087286C Thioether conjugates |
| 04/06/2004 | CA2042016C Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis |
| 04/06/2004 | CA2010321C Lymphocyte-associated cell surface protein |
| 04/01/2004 | WO2004027429A1 Process for differential diagnosis of alzheimer's dementia in patients exhibiting mild cognitive impairment |
| 04/01/2004 | WO2004027421A2 Adp assay |
| 04/01/2004 | WO2004027381A2 Methods and compositions related to inhibiting nuclear envelope breakdown |
| 04/01/2004 | WO2004027043A2 Method for production of a multimeric protein by cell fusion |
| 04/01/2004 | WO2004026911A1 Obtaining and use of therapeutic antibodies entering into the cell |
| 04/01/2004 | WO2004026910A1 Monoclonal antibody derived peptide inhibitors for mycobacterial dna gyrase |
| 04/01/2004 | WO2004026909A2 Method of treating rheumatoid arthritis by interfering with expression of dc-sign by macrophages and diagnosis thereof |
| 04/01/2004 | WO2004026908A1 Wnt MEDIATED ErbB SIGNALLING, COMPOSITIONS AND USES RELATED THERETO |
| 04/01/2004 | WO2004026901A1 M. paratuberculosis specific abc-transporter operon |
| 04/01/2004 | WO2004026891A2 Protein purification |
| 04/01/2004 | WO2004026427A2 Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds |
| 04/01/2004 | WO2004026339A1 Method Of Creating Antigens Using Emus |
| 04/01/2004 | WO2004026333A1 Treatment and diagnosis of a reproductive disorder by measuring or inhibiting interferon-ϝ |
| 04/01/2004 | WO2004026326A2 Antigen uptake receptor for candida albicans on dendritic cells |
| 04/01/2004 | WO2004026260A2 Prophylactic and therapeutic hiv aptamers |
| 04/01/2004 | WO2004026250A2 Re-activated t-cells for adoptive immunotherapy |
| 04/01/2004 | WO2004026102A2 Treatment of schizophrenia |
| 04/01/2004 | WO2004018681A3 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 04/01/2004 | WO2004013276A9 Novel tricistronic vectors and uses therefor |
| 04/01/2004 | WO2004009762A9 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 04/01/2004 | WO2004007723A3 Genes |
| 04/01/2004 | WO2004007555A3 Detection of prion disease |
| 04/01/2004 | WO2003106498A3 Ox40 (=cd134) receptor agonistic and therapeutic use |
| 04/01/2004 | WO2003106495A3 Humanized monoclonal antiboby hpam4 |
| 04/01/2004 | WO2003099868B1 Method for obtaining anti-idiotype antibodies |
| 04/01/2004 | WO2003097825A3 Novel phospholipases and uses thereof |
| 04/01/2004 | WO2003096022A3 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins |
| 04/01/2004 | WO2003091398A3 Compositions and methods for stem cell delivery |
| 04/01/2004 | WO2003090667A3 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus |
| 04/01/2004 | WO2003089934A3 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1/lap-1 |
| 04/01/2004 | WO2003087840A3 Protein involved in cancer |
| 04/01/2004 | WO2003087838A3 Compositions, methods and kits for immunochemical determination of mannan-binding lectin (mbl) |
| 04/01/2004 | WO2003085123A3 Methods anc compositions for in vivo clearance of pathogens |
| 04/01/2004 | WO2003080663A3 Tenascin-w compositions and uses thereof |
| 04/01/2004 | WO2003067221A3 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 04/01/2004 | WO2003065998A3 Immunoglobulin purification |
| 04/01/2004 | WO2003063792A3 Compositions and methods related to tim-3, a th1-specific cell surface molecule |
| 04/01/2004 | WO2003062270B1 Fluorescent protein from aequorea coerulscens and uses therof |
| 04/01/2004 | WO2003060090A3 Novel cytokine zcytor17 ligand |
| 04/01/2004 | WO2003050283A3 A structure for presenting desired peptide sequences |
| 04/01/2004 | WO2003046201A3 Detection and identification of enteric bacteria |
| 04/01/2004 | WO2003031940A3 Structural and cytoskeleton-associated proteins |
| 04/01/2004 | WO2003029282A3 Tumor-peptide antigens from the human prdi-bf1-protein |
| 04/01/2004 | WO2003025019A8 Anti-pdgf antibodies and methods for producing engineered antibodies |
| 04/01/2004 | WO2003024989A9 Activation and expansion of cells |
| 04/01/2004 | WO2003023362A3 Methods of ameliorating arthritis by modulating jnk signalsome activity |
| 04/01/2004 | WO2003014161A9 Antigen binding domains from fish |
| 04/01/2004 | WO2002092758A3 Gastrokines and derived peptides including inhibitors |
| 04/01/2004 | WO2002083847A3 Cdna encoding the human alpha2 delta4 calcium channel subunit |
| 04/01/2004 | WO2002077180A3 Novel nucleic acids and polypeptides |
| 04/01/2004 | WO2002064631A3 T1r taste receptors and genes encoding same |
| 04/01/2004 | WO2002060485A9 Use of immunoregulatory antibodies in the treatment of neoplastic disorders |
| 04/01/2004 | WO2002059377A3 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 04/01/2004 | US20040063921 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/01/2004 | US20040063917 Modified erythropoietin (epo) with reduced immunogenicity |
| 04/01/2004 | US20040063915 Comprises protein polymers coated with metal for preparation of tubulin-based cytoskeltal fibers |
| 04/01/2004 | US20040063914 Antibodies against phosphorylated VASP ( vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
| 04/01/2004 | US20040063913 Antibodies to human il-1beta |
| 04/01/2004 | US20040063908 Comprises genetically engineered hemophilus adherence and penetration (HAP) proteins for treatment and prevention of influenza; immunotherapy |
| 04/01/2004 | US20040063907 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/01/2004 | US20040063790 By administering an organic peptidomimetic vibronectin receptor alpha v beta 3 antagonist of given structures |
| 04/01/2004 | US20040063634 Modified kertinocyte growth factor (kgf) with reduced immunogenicity |
| 04/01/2004 | US20040063632 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 04/01/2004 | US20040063621 Heterocarpine, a human ghrh-binding protein |
| 04/01/2004 | US20040063605 Contacting sample containing Urokinase-type plasminogen activator (UPA) with an antibody or a labelled antibody; determining amount of antibody or labelled antibody bound to uPA-R, antibody being specific for Mo3 (glycoprotein) |
| 04/01/2004 | US20040063178 Comprises enzymatic polypeptide for identifying modulators of leukocyte adhesion and treatments of inflammatory diseases l |
| 04/01/2004 | US20040063164 Kit and method for detecting the esm-1 protein |
| 04/01/2004 | US20040063156 Materials and methods relating to the diagnosis and treatment of diabetes and obesity |
| 04/01/2004 | US20040063142 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 04/01/2004 | US20040063140 Methods for diagnosis of cancer using erbB-3 |
| 04/01/2004 | US20040063139 Comprises using nucleotide sequences coding deoxyguanosine triphosphate triphosphophydrolase to detect microorganisms in water supply |
| 04/01/2004 | US20040063135 Comprises oligonucleotides for determining concentration of glucuonidase in cell culture; detection and monitoring of malignancies and metastasis; targeted drug delivery |
| 04/01/2004 | US20040063131 Comprises neuroendocrine-specific proteins-like polypeptides (NSPLP) for diagnosis, prevention and treatment of neurodegenerative and cell proliferative diseases |
| 04/01/2004 | US20040063127 Comprises nuclelotide sequences coding cytokine for diagnosis, prevention and treatment of infection, hepatitis, nephritis, cancer and autoimmune diseases |
| 04/01/2004 | US20040063125 Transgenic cells coding membrane protein which controls intracellular hydrogen ion concentration for identifying modulators for treatment of diabetes |
| 04/01/2004 | US20040063101 Comprises nucleotide sequences coding cancer/testis (CT) antigen for diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
| 04/01/2004 | US20040062771 Clostridial toxin disease therapy |
| 04/01/2004 | US20040062768 Compositions and methods for treating hyperimmune response in the eye |
| 04/01/2004 | US20040062766 Cell separation compositions and methods |
| 04/01/2004 | US20040062765 LFA-1 alpha subunit antibodies and methods of use |
| 04/01/2004 | US20040062764 Side effect reduction; anticancer agents, antitumor agents; administering mixture of cytotoxic agent and thiol compound into arteries |
| 04/01/2004 | US20040062763 Suppression of interleukin biosynthesis; binding, complexing to antibodies; therapy for endotoxin shock |
| 04/01/2004 | US20040062762 Method of sterilizing antibody-containing milk and products containing sterilized antibody-containing milk |
| 04/01/2004 | US20040062761 Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer |
| 04/01/2004 | US20040062749 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 04/01/2004 | US20040060568 Hedgehog antagonists, methods and uses related thereto |
| 04/01/2004 | CA2767235A1 Peptides and related molecules that modulate nerve growth factor activity |
| 04/01/2004 | CA2539477A1 Treatment and diagnosis of a reproductive disorder by measuring or inhibiting interferon-.gamma. |
| 04/01/2004 | CA2499321A1 Obtaining and use of therapeutic antibodies entering into the cell |